نتایج جستجو برای: t cell vaccination

تعداد نتایج: 2220123  

2016
Eleni Panagioti Anke Redeker Suzanne van Duikeren Kees Lmc Franken Jan Wouter Drijfhout Sjoerd H van der Burg Ramon Arens

There is an ultimate need for efficacious vaccines against human cytomegalovirus (HCMV), which causes severe morbidity and mortality among neonates and immunocompromised individuals. In this study we explored synthetic long peptide (SLP) vaccination as a platform modality to protect against mouse CMV (MCMV) infection in preclinical mouse models. In both C57BL/6 and BALB/c mouse strains, prime-b...

Journal: :Journal of immunology 2009
Takemasa Tsuji Nasser K Altorki Gerd Ritter Lloyd J Old Sacha Gnjatic

Vaccination with cancer/testis Ag MAGE-A3 in the form of recombinant protein often induces specific humoral and cellular immune responses. Although Ag-specific CD4+ T cells following vaccination are detectable by cytokine production after a single in vitro stimulation, their detection before vaccination is difficult because of low frequency. In this study, we have applied a sensitive method usi...

Journal: :Clinical & Experimental Immunology 2008

Journal: :Journal of immunology 2012
Rohan Dhiman Sivakumar Periasamy Peter F Barnes Ankita Garg Jaiswal Padmaja Paidipally Amanda B Barnes Amy Tvinnereim Ramakrishna Vankayalapati

We previously found that human NK cells lyse Mycobacterium tuberculosis-infected monocytes and alveolar macrophages and upregulate CD8(+) T cell responses. We also found that human NK cells produce IL-22, which inhibits intracellular growth of M. tuberculosis, and that NK cells lyse M. tuberculosis-expanded CD4(+)CD25(+)FOXP3(+) T regulatory cells (Tregs). To determine the role of NK cells duri...

2012
Melanie Kremer Yasemin Suezer Asisa Volz Theresa Frenz Monir Majzoub Kay-Martin Hanschmann Michael H. Lehmann Ulrich Kalinke Gerd Sutter

Vaccination is highly effective in preventing various infectious diseases, whereas the constant threat of new emerging pathogens necessitates the development of innovative vaccination principles that also confer rapid protection in a case of emergency. Although increasing evidence points to T cell immunity playing a critical role in vaccination against viral diseases, vaccine efficacy is mostly...

Journal: :The Journal of Experimental Medicine 2008
Sang-Jun Ha Scott N. Mueller E. John Wherry Daniel L. Barber Rachael D. Aubert Arlene H. Sharpe Gordon J. Freeman Rafi Ahmed

Therapeutic vaccination is a potentially promising strategy to enhance T cell immunity and viral control in chronically infected individuals. However, therapeutic vaccination approaches have fallen short of expectations, and effective boosting of antiviral T cell responses has not always been observed. One of the principal reasons for the limited success of therapeutic vaccination is that virus...

Journal: :Infection and immunity 1998
O Denis A Tanghe K Palfliet F Jurion T P van den Berg A Vanonckelen J Ooms E Saman J B Ulmer J Content K Huygen

Vaccination of mice with plasmid DNA carrying the gene for the major secreted mycobacterial antigen 85A (Ag85A) from Mycobacterium tuberculosis is a powerful technique for generating robust specific Thl helper T-cell responses, CD8+-mediated cytotoxicity, and protection against M. tuberculosis challenge (K. Huygen et al., Nat. Med. 2:893-898, 1996). We have now analyzed in more detail the antig...

Journal: :Clinical and vaccine immunology : CVI 2013
Mohammad Murshid Alam Daniel T Leung Marjahan Akhtar Mohammad Nazim Sarmin Akter Taher Uddin Farhana Khanam Deena Al Mahbuba Shaikh Meshbahuddin Ahmad Taufiqur Rahman Bhuiyan Stephen B Calderwood Edward T Ryan Firdausi Qadri

Antibody avidity for antigens following disease or vaccination increases with affinity maturation and somatic hypermutation. In this study, we followed children and adults in Bangladesh for 1 year following oral cholera vaccination and measured the avidity of antibodies to the T cell-dependent antigen cholera toxin B subunit (CTB) and the T cell-independent antigen lipopolysaccharide (LPS) in c...

2014
Jennifer Nayak Andrea Sant Shabnam Alam

Background. Vaccination against pandemic influenza poses significant challenges as the viral strain that will be responsible for the next influenza pandemic is unpredictable. Given the time lag between initiation of a pandemic and significant vaccine production, a pandemic vaccine will rarely be available until after significant viral circulation has occurred. One possible strategy to circumven...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید